MiniMed董事会迎来爱尔康CEO及美敦力高管

环球市场播报06-29

　　糖尿病技术公司MiniMed周一宣布，任命爱尔康首席执行官David Endicott与美敦力高管Linnea Burman为公司董事会成员，即日生效。董事会规模从9人扩大至11人。

　　Endicott目前担任全球眼科护理巨头爱尔康的首席执行官，自2019年起担任爱尔康董事，此前主导了爱尔康从诺华分拆并重返公开市场的全过程。MiniMed首席执行官Que Dallara表示，Endicott拥有数十年跨医疗健康领域的运营领导经验，其主导分拆上市的亲身经历对MiniMed作为独立公司发展尤为重要。

　　Endicott的职业生涯涵盖多家全球制药和医疗器械企业，曾在辉瑞旗下Hospira输液系统公司担任总裁，并在艾尔建任职超过25年，领导业务覆盖美国、欧洲、亚洲及拉丁美洲。他将在MiniMed薪酬与人才委员会任职。

　　Burman现任美敦力高级副总裁兼神经血管业务总裁，在美敦力任职超过19年，历任使能技术、颅脑及脊柱技术、盆腔健康与胃部治疗等业务的副总裁及总经理。美敦力在MiniMed今年早些时候完成分拆及IPO后仍为其最大股东，并指定Burman出任董事会成员。

　　MiniMed于今年从美敦力分拆独立上市，专注于胰岛素输送系统、持续血糖监测及算法技术，服务全球超过80个国家的糖尿病患者。

海量资讯、精准解读，尽在新浪财经APP

责任编辑：张俊 SF065

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2647308228?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-06-29 23:06","share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","id":"2647308228","market":"other","top_or_hot":-1,"title":"MiniMed董事会迎来爱尔康CEO及美敦力高管","media":"环球市场播报","content":"<html><body><div>\n<p>　　糖尿病技术公司MiniMed周一宣布，任命爱尔康首席执行官David Endicott与<span><a href=\"https://laohu8.com/S/MDT\">美敦力</a></span><span></span>高管Linnea Burman为公司董事会成员，即日生效。董事会规模从9人扩大至11人。</p>\n<p>　　Endicott目前担任全球眼科护理巨头爱尔康的首席执行官，自2019年起担任爱尔康董事，此前主导了爱尔康从<span><a href=\"https://laohu8.com/S/NVS\">诺华</a></span><span></span>分拆并重返公开市场的全过程。MiniMed首席执行官Que Dallara表示，Endicott拥有数十年跨医疗健康领域的运营领导经验，其主导分拆上市的亲身经历对MiniMed作为独立公司发展尤为重要。</p>\n<p>　　Endicott的职业生涯涵盖多家全球制药和医疗器械企业，曾在<span><a href=\"https://laohu8.com/S/PFE\">辉瑞</a></span><span></span>旗下Hospira输液系统公司担任总裁，并在艾尔建任职超过25年，领导业务覆盖美国、欧洲、亚洲及拉丁美洲。他将在MiniMed薪酬与人才委员会任职。</p>\n<p>　　Burman现任美敦力高级副总裁兼神经血管业务总裁，在美敦力任职超过19年，历任使能技术、颅脑及脊柱技术、盆腔健康与胃部治疗等业务的副总裁及总经理。美敦力在MiniMed今年早些时候完成分拆及IPO后仍为其最大股东，并指定Burman出任董事会成员。</p>\n<p>　　MiniMed于今年从美敦力分拆独立上市，专注于胰岛素输送系统、持续血糖监测及算法技术，服务全球超过80个国家的糖尿病患者。</p>\n<div>\n<div><img src=\"\"/></div>\n<div>海量资讯、精准解读，尽在新浪财经APP</div>\n</div>\n<p>责任编辑：张俊 SF065</p>\n</div></body></html>","source":"sina","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MiniMed董事会迎来爱尔康CEO及美敦力高管</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMiniMed董事会迎来爱尔康CEO及美敦力高管\n</h2>\n\n<h4 class=\"meta\">\n\n</h4>\n\n</header>\n<article>\n<html><body><div>\n<p>　　糖尿病技术公司MiniMed周一宣布，任命爱尔康首席执行官David Endicott与<span><a href=\"https://laohu8.com/S/MDT\">美敦力</a></span><span></span>高管Linnea Burman为公司董事会成员，即日生效。董事会规模从9人扩大至11人。</p>\n<p>　　Endicott目前担任全球眼科护理巨头爱尔康的首席执行官，自2019年起担任爱尔康董事，此前主导了爱尔康从<span><a href=\"https://laohu8.com/S/NVS\">诺华</a></span><span></span>分拆并重返公开市场的全过程。MiniMed首席执行官Que Dallara表示，Endicott拥有数十年跨医疗健康领域的运营领导经验，其主导分拆上市的亲身经历对MiniMed作为独立公司发展尤为重要。</p>\n<p>　　Endicott的职业生涯涵盖多家全球制药和医疗器械企业，曾在<span><a href=\"https://laohu8.com/S/PFE\">辉瑞</a></span><span></span>旗下Hospira输液系统公司担任总裁，并在艾尔建任职超过25年，领导业务覆盖美国、欧洲、亚洲及拉丁美洲。他将在MiniMed薪酬与人才委员会任职。</p>\n<p>　　Burman现任美敦力高级副总裁兼神经血管业务总裁，在美敦力任职超过19年，历任使能技术、颅脑及脊柱技术、盆腔健康与胃部治疗等业务的副总裁及总经理。美敦力在MiniMed今年早些时候完成分拆及IPO后仍为其最大股东，并指定Burman出任董事会成员。</p>\n<p>　　MiniMed于今年从美敦力分拆独立上市，专注于胰岛素输送系统、持续血糖监测及算法技术，服务全球超过80个国家的糖尿病患者。</p>\n<div>\n<div><img src=\"\"/></div>\n<div>海量资讯、精准解读，尽在新浪财经APP</div>\n</div>\n<p>责任编辑：张俊 SF065</p>\n</div></body></html>\n\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://finance.sina.com.cn/stock/usstock/c/2026-06-29/doc-inifayqu3714964.shtml\">环球市场播报</a> </p>\n\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n</div>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0208291251.USD","symbol_name":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) INC","start_time":0,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-06-29/doc-inifayqu3714964.shtml","article_id":"2647308228","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2647308228","pubTimestamp":1782745560,"columns":[],"sourceInfo":{"source_id":"sina","name":"sina"},"weMediaInfo":null,"summary":"糖尿病技术公司MiniMed周一宣布，任命爱尔康首席执行官David Endicott与美敦力高管Linnea Burman为公司董事会成员，即日生效。董事会规模从9人扩大至11人。他将在MiniMed薪酬与人才委员会任职。美敦力在MiniMed今年早些时候完成分拆及IPO后仍为其最大股东，并指定Burman出任董事会成员。　　MiniMed于今年从美敦力分拆独立上市，专注于胰岛素输送系统、持续血糖监测及算法技术，服务全球超过80个国家的糖尿病患者。","collect":0,"end_time":0,"defaultTopTitle":"sina.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU0208291251.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) INC","IE00B3T34201.USD":"BNY MELLON GLOBAL EQUITY INCOME \"B\" (USD) INC","IE00BQXX3D17.EUR":"GUINNESS GLOBAL INNOVATORS \"C\" (EUR) ACC","LU0070302665.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) ACC","LU0106261372.USD":"SCHRODER ISF US LARGE CAP \"A\" ACC","LU0162691827.USD":"BGF US BASIC VALUE \"A4\" INC","IE00BQXX3C00.GBP":"GUINNESS GLOBAL INNOVATORS \"C\" (GBP) ACC","LU1116320901.HKD":"BGF SYSTEMATIC GLOBAL ENHANCED EQUITY YIELD \"A6\" (HKD) INC","IE000M9KFDE8.USD":"NEUBERGER BERMAN US LARGE CAP VALUE \"A\" (USD) ACC","LU1989771016.USD":"东方汇理环球老龄化投资基金 A2 Acc","LU1291159041.SGD":"CPR Invest - Global Silver Age A2 Acc SGD-H","LU2271345857.HKD":"ALLIANZ GLOBAL SUSTAINABILITY \"AT\" (HKD) ACC","IE00BQXX3F31.USD":"GUINNESS GLOBAL INNOVATORS \"C\" (USD) ACC","MDT":"美敦力","LU1244550577.SGD":"FTIF - Franklin Global Multi-Asset Income A (Mdis) SGD-H1","LU0314106906.USD":"MANULIFE GF GLOBAL EQUITY \"AA\" (USD) INC","IE00BVYPNW00.USD":"GUINNESS GLOBAL EQUITY INCOME \"C\" (USD) ACC","BK4585":"ETF&股票定投概念","LU0211326839.USD":"TEMPLETON GLOBAL INCOME \"A\" (USD) INC","LU2468319806.SGD":"MANULIFE GF HEALTHCARE \"AA\" (SGDHDG) ACC","LU0320765489.SGD":"FTIF - Franklin Mutual US Value A Acc SGD","BK4533":"AQR资本管理(全球第二大对冲基金)","LU0496365809.HKD":"TEMPLETON GLOBAL INCOME \"A\" (HKD) INC (Q)","LU1244550221.USD":"FRANKLIN GLOBAL MULTI-ASSET  INCOME \"A\" (USDHEDGED) INC (M)","LU0211326755.USD":"TEMPLETON GLOBAL INCOME \"A\" (USD) ACC","LU1571399168.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"IP\" (USD) ACC","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","BK4566":"资本集团","LU0211331839.USD":"FRANKLIN MUTUAL GLB DISCOVERY \"A\" (USD) ACC","LU0158827948.USD":"ALLIANZ GLOBAL SUSTAINABILITY \"A\" (USD) INC","LU0265550359.USD":"BGF SYSTEMATIC GLOBAL ENHANCED EQUITY YIELD \"A2\" (USD) ACC","LU1989764664.SGD":"CPR Invest - Global Disruptive Opportunities A2 Acc SGD-H","LU0158827781.USD":" ALLIANZ GLOBAL SUSTAINABILITY \"AT\" (USD) ACC","LU2028103732.USD":"ALLIANZ GLOBAL SUSTAINABILITY \"AMG\" (USD) INC","IE00BFXG1179.USD":"BNY MELLON U.S. EQUITY INCOME \"B\" (USD) INC","BK4082":"医疗保健设备","LU1989764748.USD":"东方汇理环球颠覆性机遇A2 Acc","IE00BDGV0183.EUR":"GUINNESS GLOBAL EQUITY INCOME \"C\" (EUR) INC","LU2089283258.USD":"安联环球可持续基金Cl AM Dis","LU2089984988.USD":"MANULIFE GF HEALTHCARE \"AA\" (USD) ACC","LU0432979614.USD":"JPM GLOBAL HEALTHCARE \"A\" ACC","IE00BGHQF631.EUR":"GUINNESS GLOBAL EQUITY INCOME \"C\" (EUR) ACC","LU2112291526.USD":"BGF WORLD HEALTHSCIENCE \"A4\" (USD) INC","LU1116320737.USD":"BGF SYSTEMATIC GLOBAL ENHANCED EQUITY YIELD \"A6\" (USD) INC","LU1506573853.SGD":"MANULIFE GF GLOBAL EQUITY \"AA\" (SGD) INC","LU0265550946.USD":"BGF SYSTEMATIC GLOBAL ENHANCED EQUITY YIELD \"A5\" (USD) INC","IE00B3PB1722.GBP":"GUINNESS GLOBAL EQUITY INCOME \"C\" (GBP) INC","BK4588":"碎股","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","IE00B42XCP33.USD":"GUINNESS GLOBAL EQUITY INCOME \"C\" (USD) INC"},"translate_title":"MiniMed Board Welcomes Alcon CEO and Medtronic Executives","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MDT":1.5},"content_text":"糖尿病技术公司MiniMed周一宣布，任命爱尔康首席执行官David Endicott与美敦力高管Linnea Burman为公司董事会成员，即日生效。董事会规模从9人扩大至11人。\n　　Endicott目前担任全球眼科护理巨头爱尔康的首席执行官，自2019年起担任爱尔康董事，此前主导了爱尔康从诺华分拆并重返公开市场的全过程。MiniMed首席执行官Que Dallara表示，Endicott拥有数十年跨医疗健康领域的运营领导经验，其主导分拆上市的亲身经历对MiniMed作为独立公司发展尤为重要。\n　　Endicott的职业生涯涵盖多家全球制药和医疗器械企业，曾在辉瑞旗下Hospira输液系统公司担任总裁，并在艾尔建任职超过25年，领导业务覆盖美国、欧洲、亚洲及拉丁美洲。他将在MiniMed薪酬与人才委员会任职。\n　　Burman现任美敦力高级副总裁兼神经血管业务总裁，在美敦力任职超过19年，历任使能技术、颅脑及脊柱技术、盆腔健康与胃部治疗等业务的副总裁及总经理。美敦力在MiniMed今年早些时候完成分拆及IPO后仍为其最大股东，并指定Burman出任董事会成员。\n　　MiniMed于今年从美敦力分拆独立上市，专注于胰岛素输送系统、持续血糖监测及算法技术，服务全球超过80个国家的糖尿病患者。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张俊 SF065","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"executive","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2647308228","isCrawlerRequest":true}